In prostate cancer, NAT10 promotes metastasis by acetylating Keratin 8 (KRT8) mRNA to enhance its stability, downregulating E-cadherin and upregulating N-cadherin protein expression, thereby activating EMT (Li et al., 2024). Here, KRT8 is linked to prostate carcinoma.